Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Novartis Vaccines And Diagnostics Inc. patentsThe following is a sampling of recent Novartis Vaccines And Diagnostics Inc. patent applications (USPTO Patent Application #, Patent Title) sorted by month.
July 2011 - Novartis Vaccines And Diagnostics Inc. patents
20110183338 - Two stage enrichment of cell-free fetal dna in maternal plasma
20110171640 - Method for isolating cell free apoptotic or fetal nucleic acids
June 2011 - Novartis Vaccines And Diagnostics Inc. patents
20110158977 - Immunogenic compositions for chlamydia trachomatis
May 2011 - Novartis Vaccines And Diagnostics Inc. patents
20110110982 - Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
March 2011 - Novartis Vaccines And Diagnostics Inc. patents
20110065146 - Expression of hiv polypeptides and production of virus-like particles
20110052632 - Hiv polynucleotides and polypeptides derived from botswana mj4
20110053140 - Methods and reagents for diagnosing hantavirus infection
February 2011 - Novartis Vaccines And Diagnostics Inc. patents
20110045015 - Conjugated beta-1,3-linked glucans
20110045017 - Hiv vaccine for mucosal delivery
20110045022 - Vaccines including antigen from four strains of influenza virus
20110045457 - Assays for adsorbed influenza vaccines
20110038879 - Immunogenic and therapeutic compositions for streptococcus pyogenes
20110038900 - Nanoparticles for use in pharmaceutical compositions
20110033485 - Analogues of glycolipids useful as immunoadjuvants
20110034462 - Organic compounds
20110027314 - Influenza vaccines containing hemagglutinin and matrix proteins
January 2011 - Novartis Vaccines And Diagnostics Inc. patents
20110020352 - Endogenous retroviruses up-regulated in prostate cancer
20110020385 - Combinations of pneumococcal rrgb clades
20110020390 - Meningococcal fhbp polypeptides
20110020396 - Hiv envelope-cd4 complexes and hybrids
20110022023 - Unitary withdrawal spike unit suitable for factory fitting
20110014219 - Norovirus and sapovirus antigens
20110014230 - preparation of influenza virus vaccine antigens
20110014652 - Norovirus and sapovirus antigens
20110008279 - Methods and compositions relating to adhesins as adjuvants
20110002958 - Alphavirus vectors for respiratory pathogen vaccines
20110003300 - Rapid sterility microassay
December 2010 - Novartis Vaccines And Diagnostics Inc. patents
20100330121 - Recombinant alphavirus-based vectors with reduced inhibition of cellular macro-molecular synthesis
20100322958 - Modified saccharides
20100324272 - Pancreatic cancer genes
20100316698 - Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
20100303822 - Polypeptides from non-typeable haemophilus influenzae
20100303864 - Conserved and specific streptococcal genomes
November 2010 - Novartis Vaccines And Diagnostics Inc. patents
20100297164 - Chlamydial antigens
20100291129 - Norovirus and sapovirus antigens
20100291134 - Truncated hepatitis c virus ns5 domain and fusion proteins comprising same
20100291598 - Prion elisa
20100282684 - Lipopolysaccharide decontamination
20100285062 - Combined mucosal and parenteral immunization against hiv
20100285069 - Meningococcal vaccine formulations
20100285135 - Nanoparticles for use in immunogenic compositions
October 2010 - Novartis Vaccines And Diagnostics Inc. patents
20100272725 - Neisserial antigens
20100272755 - Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
20100266626 - Adjuvanted glucans
20100266631 - Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
20100267931 - Heterologous expression of neisserial proteins
20100253934 - Analysis of mixtures including proteins
20100255002 - Immunogenic compositions for chlamydia trachomatis
20100256375 - Substituted benzimidazoles and methods of preparation
September 2010 - Novartis Vaccines And Diagnostics Inc. patents
20100239600 - Conjugate purification
20100239607 - Compositions for inducing immune responses
20100233187 - Gene products differentially expressed in cancerous cells
20100233205 - Adjuvanted antigenic meningococcal compositions
20100234394 - Substituted benzimidazoles and methods of their use
20100226931 - Compounds for immunopotentiation
20100226937 - Combination vaccines with 1-hydroxy-2-phenoxyethane preservative
20100227311 - Tissue culture system for production of hepatitis c virus
20100219335 - Liquid chromatography-mass spectrometry analysis of samples using ionic eluent comprising a volatile ionic salt
20100221256 - Meningococcus adhesins nada, app and orf 40
20100221278 - Immunogenic compositions for streptococcus pyogenes
August 2010 - Novartis Vaccines And Diagnostics Inc. patents
20100203074 - Compositions and methods for treating intracellular diseases
20100203137 - Formulation of meningitis vaccines
20100203501 - Assay to detect hcv receptor binding
20100196339 - Microparticle-based transfection and activation of dendritic cells
20100196934 - Prion assay
July 2010 - Novartis Vaccines And Diagnostics Inc. patents
20100189737 - Meningococcal vaccines including hemoglobin receptor
20100183653 - Fusion proteins comprising cd4 minimal modules and methods of use thereof
20100183671 - Low-additive influenza vaccines
20100183674 - Compositions comprising yersinia pestis antigens
20100173412 - Eukaryotic layered vector initiation systems
20100166788 - Immunogens from uropathogenic escherichia coli
June 2010 - Novartis Vaccines And Diagnostics Inc. patents
20100158935 - Mutant forms of streptolysin o
20100158940 - Manufacture of booster vaccines having reduced antigen doses
20100158943 - Administration routes for priming/boosting with influenza vaccines
20100150912 - Blocking interaction between pathogen factors and factor h to inhibit hemorrhagic syndromes
20100150943 - Immunogenic compositions for gram positive bacteria
20100143293 - T cell activation
20100143418 - Immunising against meningococcal serogroup y using proteins
20100136041 - Combination gas vaccines and therapeutics
20100136522 - Endogenous retroviruses up-regulated in prostate cancer
May 2010 - Novartis Vaccines And Diagnostics Inc. patents
20100129826 - Double stranded rna receptor (dsrna-r) and methods relating thereto
20100114058 - Multidose vial assemblies and adapters therefor
April 2010 - Novartis Vaccines And Diagnostics Inc. patents
20100104593 - Meningococcal conjugate vaccination
20100105875 - Antibodies against neisserial factor h binding protein
20100098697 - Chlamydia trachomatis antigens
20100098718 - Nucleic acid vectors for immunization
20100092502 - Modified hiv env polypeptides
20100092503 - Hcv fusion polypeptideds
20100092509 - Hypo- and hyper- acetylated meningococcal capsular saccharides
20100086565 - Vectors for expression of hml-2 polypeptides
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Novartis Vaccines And Diagnostics Inc. in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Novartis Vaccines And Diagnostics Inc. with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support - Terms & Conditions
|
REGISTER now for FREE 
